Nurses News

 
 
  • AGA Issues Guidance on Using P-CABs Factors such as cost, access, and lack of long-term safety data may influence how P-CABs are integrated into practice.
  • Metronomic Therapy Shows Promise in Breast Cancer Patients with HR+/HER2− metastatic breast cancer without previous systemic therapy were randomly assigned to receive either metronomic capecitabine plus AI or AI alone.
  • New Health Cybersecurity Rule: What Docs Should Know A proposed federal rule would require hospitals and physicians’ groups to beef up health cybersecurity measures to protect patient privacy and prevent ransomware attacks. Some changes could be expensive, experts said.
  • What’s the Best Approach for Sustained Weight Loss? With nutritional, pharmaceutical, and surgical options available for obesity, clinicians are being called upon to make decisions about how to best help their patients lose weight and keep it off.
  • Are Patients On GLP-1s Getting the Right Nutrients? As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can clinicians support their patients’ nutritional needs?
  • Long-Term Budesonide Shows Sustained Efficacy in EoE Long-term budesonide orodispersible tablets effectively maintained remission in patients with eosinophilic esophagitis and demonstrated a favorable safety profile.
  • End-of-Life Care Talks Occur Late for Young Cancer Patients Documented palliative goals of care rarely occurred among adolescents and younger adults with cancer before the last 30 days of life.
  • AI and the Art of Nursing As artificial intelligence makes its way to nursing, nurses navigate between cutting-edge technology and the human touch.
  • Alert J&J Halts Varipulse Field Ablation for AFib The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.
  • Dementia Risk Higher for Stroke Survivors Dementia risk is nearly 80% higher in stroke survivors than in those without stroke, with risk declining within 1 year but remaining elevated for up to 20 years, data show.
  • Empathy-focused Calls Boost Diabetes Self-Care Empathetic calls made by laypeople with a goal to learn more about the patient improved glycemic control in low-income patients with diabetes, a 6-month parallel-arm superior trial showed.
  • No-Implant Shunt Wins FDA Breakthrough Status for HF The new approach is designed to create a connection between the left and right atrial chambers of the heart in a single procedure without leaving an implant behind.
  • hMPV: Is There Cause for Concern? Reports of rising hMPV infections in China have attracted media attention, but experts say the virus poses low pandemic risk owing to widespread immunity.
  • AI-Enhanced ECG Predicts Hypertension, Related Risks A new AI-ECG risk estimation model can predict the development of hypertension and flag patients who may require more monitoring.
  • Leaving ED Without Being Seen Entails Increasing Risks Researchers call for long-term, consistent funding for primary, emergency, hospital, and long-term care.
  • SABCS 2024 Can Some Patients Safely Skip Postmastectomy Radiation? Most women with intermediate-risk breast cancer can safely skip chest wall irradiation after mastectomy and avoid the risks for chest wall pain, fibrosis, heart damage, and lung cancer.
  • Why Aren’t More PCPs Offering Contraceptive Services? Experts say the primary care workforce is well suited to meet patients’ contraceptive needs but the numbers of primary care physicians offering prescriptions and procedures is strikingly low.
  • Biomarkers Predict Lung Disease Outcome in SSc-ILD Therapy Patients with SSc-ILD who showed an increase in the level of blood biomarker KL-6 after 1 year of treatment were at risk of developing progressive pulmonary fibrosis in the second year.
  • KRAS Mutation Types Shape Pancreatic Cancer Outcomes Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.
  • Incentives Do Not Boost Prostate Cancer Active Surveillance A cohort study analyzed data from 15,273 men with prostate cancer to determine active surveillance rates at difference points in time.